SABS

SABS

SAB Biotherapeutics Inc. Common Stock

$1.831+0.000 (0.000%)

Precio en Tiempo Real

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.831

Máximo

$1.831

Mínimo

$1.831

Volumen

0.01M

Fundamentos de la Empresa

Estadísticas de Negociación

Noticias Relacionadas

Analyst Upgrades

Chardan Capital Maintains Buy on SAB Biotherapeutics, Maintains $20 Price Target

Chardan Capital analyst Keay Nakae maintains SAB Biotherapeutics with a Buy and maintains $20 price target.

Ver más
Chardan Capital Maintains Buy on SAB Biotherapeutics, Maintains $20 Price Target
Analyst Upgrades

HC Wainwright & Co. Assumes SAB Biotherapeutics at Buy, Announces Price Target of $10

HC Wainwright & Co. analyst Emily Bodnar assumes SAB Biotherapeutics with a Buy rating and announces Price Target of $10.

Ver más
HC Wainwright & Co. Assumes SAB Biotherapeutics at Buy, Announces Price Target of $10